WhiteSwell Medical
Acute Decompensated Heart Failure Treatment
Company Overview
Snapshot
Founded in September 2014, WhiteSwell Medical operates with 11–50 employees. The company has raised $30 million across one funding round from two investors. In December 2018, WhiteSwell Medical secured $30 million in funding.
Business overview
WhiteSwell Medical is a science-driven company focused on improving the treatment of acute decompensated heart failure (ADHF), a major cause of repeat hospitalizations. The company is developing a minimally invasive, catheter-based approach designed to enhance the natural fluid-removal process of the lymphatic system, thereby more efficiently removing excess interstitial fluid in ADHF patients. It operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.
Strategic signal
In January 2022, WhiteSwell Medical expanded its senior management team with experienced executives. This move signals a strategic strengthening of leadership, likely in preparation for further development, clinical trials, or market entry for its catheter-based ADHF treatment. For investors, this indicates a company building out its operational capabilities and expertise to advance its innovative medical device.
Log in to access full profile ›Company Intelligence Q&A
- What is WhiteSwell Medical's primary focus?
- WhiteSwell Medical is dedicated to improving the treatment of acute decompensated heart failure (ADHF) through a minimally invasive, catheter-based approach that enhances the lymphatic system's natural fluid-removal process.
- When was WhiteSwell Medical founded?
- WhiteSwell Medical was founded in September 2014.
- How much funding has WhiteSwell Medical raised?
- WhiteSwell Medical has raised a total of $30 million. This funding was secured in a single round in December 2018.
- Which investors participated in WhiteSwell Medical's funding round?
- In December 2018, WhiteSwell Medical secured $30 million in funding from RA Capital Management and InCube Ventures.
- What recent strategic development has WhiteSwell Medical undertaken?
- In January 2022, WhiteSwell Medical added experienced executives to its senior management team, strengthening its leadership for future growth and operational advancements.